The customer and market requirements for the aseptic filling of medicines are steadily increasing. There is a clear trend to smaller batches for different types of ready-to-use containers (vials, syringes, cartridges) and high value drugs. At the same time approximately 25% of all NCEs are classified as high-potency with OELs (occupational exposure limits) below 10ug/m3 with this number expected to grow. This leads to a growing need for flexibility within the life science industry and therefore the need for development of new flexible and modular equipment as well as modular facilities. In this session the different presentations will cover the development of a new flexible production cell, the development of a flexible state-of-the-art facility for high-potency manufacturing and finally how modular facilities can accelerate product development while reducing development costs.